YTEN's Business Model
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.
| Sector & Industry | Basic Materials / Agricultural Inputs |
| Website | https://www.yield10bio.com |
| CEO (Chief Executive Officer) | Oliver P. Peoples |
| Number of Employees | |
| IPO date | November 10, 2006 |
YTEN Latest News
|
|
|
|
|
|
|
|
|
|
| Contact | |
|---|---|
| Country | US |
| Address | 19 Presidential Way |
| City | Woburn |
| State | MA |
| Phone | 617 583 1700 |
| Zip Code | 01801 |
| Other Identifiers | |
| CIK | 0001121702 |
| ISIN | US98585K8624 |
| CUSIP | 98585K862 |
| Open | 0.6949 |
| Previous Close | None |
| Volume | 11.43 Thou. |
| Average Volume | 5.09 Thou. |
| Day’s Range | 0.33505 – 0.6949 |
| 52 Week Range | 0.2352-17.255999 |
| MA (50) | 0.5575032 |
| MA (200) | 2.3373854 |
| Market Cap | 345.5 Thou. |
| Shares Out. | 1.03 Mil. |
| Earnings Date | Dec 16, 2024 |
| Beta | |
| Last Dividend | |
| EPS | |
| PE | |
